Rafael Holdings, Inc. Class B Common Stock (RFL)

Price$1.24

Favorite Metrics

Price vs S&P 500 (26W)-14.72%

Price vs S&P 500 (4W)-7.88%

Market Capitalization$65.55M

All Metrics

Book Value / Share (Quarterly)$1.53

P/TBV (Annual)1.41x

Revenue Growth (3Y)30.78%

Cash Flow / Share (Quarterly)$-0.54

Price vs S&P 500 (YTD)2.64%

Gross Margin (TTM)93.12%

Net Profit Margin (TTM)-2846.60%

EPS (TTM)$-0.78

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$-0.78

Revenue Growth (5Y)-28.51%

EPS (Annual)$-1.02

ROI (Annual)-32.10%

Gross Margin (Annual)85.39%

Net Profit Margin (5Y Avg)-8574.79%

Cash / Share (Quarterly)$0.73

Revenue Growth QoQ (YoY)174.03%

ROA (Last FY)-26.75%

Revenue Growth TTM (YoY)64.73%

EBITD / Share (TTM)$-0.81

ROE (5Y Avg)-44.04%

Operating Margin (TTM)-3044.20%

Cash Flow / Share (Annual)$-0.36

P/B Ratio0.83x

P/B Ratio (Quarterly)0.77x

Net Income / Employee (Annual)$-1

EV / Revenue (TTM)24.45x

Net Interest Coverage (TTM)-6.64x

ROA (TTM)-31.02%

EPS Incl Extra (Annual)$-1.02

Current Ratio (Annual)4.89x

Quick Ratio (Quarterly)3.08x

3-Month Avg Trading Volume0.11M

52-Week Price Return-21.25%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.90

P/S Ratio (Annual)71.48x

Asset Turnover (Annual)0.01x

52-Week High$3.19

Operating Margin (5Y Avg)-12541.74%

EPS Excl Extra (Annual)$-1.02

CapEx CAGR (5Y)-47.57%

Tangible BV CAGR (5Y)-11.70%

26-Week Price Return-5.97%

Quick Ratio (Annual)4.71x

13-Week Price Return-1.56%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)3.44x

Enterprise Value$28.431

Revenue / Share Growth (5Y)-37.09%

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-24.57%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-3620.07%

Cash / Share (Annual)$1.01

3-Month Return Std Dev51.89%

Net Income / Employee (TTM)$-2

ROE (Last FY)-32.33%

Net Interest Coverage (Annual)-1.88x

EPS Basic Excl Extra (Annual)$-1.02

Receivables Turnover (TTM)4.70x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.78

Receivables Turnover (Annual)1.74x

ROI (TTM)-38.72%

P/S Ratio (TTM)56.36x

Pretax Margin (5Y Avg)-10874.37%

Revenue / Share (Annual)$0.03

Tangible BV / Share (Annual)$1.18

Price vs S&P 500 (52W)-56.34%

Year-to-Date Return6.78%

5-Day Price Return4.13%

EPS Normalized (Annual)$-1.02

ROA (5Y Avg)-37.10%

Net Profit Margin (Annual)-3328.24%

Month-to-Date Return0.80%

Cash Flow / Share (TTM)$-0.36

EBITD / Share (Annual)$-0.96

Operating Margin (Annual)-3179.83%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-40.11%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.78

P/TBV (Quarterly)1.31x

P/B Ratio (Annual)0.92x

Pretax Margin (TTM)-2988.48%

Book Value / Share (Annual)$1.80

Price vs S&P 500 (13W)-4.43%

Beta0.51x

Revenue / Share (TTM)$0.02

ROE (TTM)-39.03%

52-Week Low$1.12

Industry Peers — Pharmaceuticals(308)

Symbol	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
RFLRafael Holdings, Inc. Class B Common Stock	56.36x	64.73%	93.12%	—	$1.24
LLYEli Lilly & Co.	13.45x	44.70%	83.04%	27.59%	$919.90
JNJJohnson & Johnson	5.82x	7.87%	67.95%	14.90%	$230.69
ABBVABBVIE INC.	5.97x	8.57%	71.62%	-2.88%	$203.71
MRKMerck & Co., Inc.	4.51x	1.31%	78.55%	21.23%	$117.10
AZNAstraZeneca PLC	5.39x	8.63%	81.31%	21.88%	$200.69
NVSNovartis AG	4.87x	8.91%	75.82%	15.26%	$150.99
NVONovo-Nordisk A/S	3.74x	6.43%	80.98%	20.66%	$40.46
ABTAbbott Laboratories	3.71x	6.59%	56.50%	8.20%	$96.00
PFEPfizer Inc.	2.50x	-1.64%	75.81%	-3.51%	$27.52
BMYBristol-Myers Squibb Co.	2.52x	-0.22%	72.63%	—	$59.13

About

Rafael Holdings is a biotechnology company with a lead asset, Trappsol Cyclo, in Phase 3 trials for Niemann-Pick Disease Type C1. The company pursues regulatory approval and commercialization while maintaining a diversified portfolio of clinical and early-stage pharmaceutical and medical device investments. Operations span three segments—healthcare, infusion technology, and real estate—with locations in the United States and Israel.